TQS sets a High Bar in Serialisation and Aggregation Lines at Boehringer Ingelheim

04/28/2021

Compliance by Precision

As one of the world’s 20 leading pharmaceutical companies, the Boehringer Ingelheim group operates globally with 175 affiliates and employs more than 51,000 professionals. Since it exports pharmaceuticals to different markets worldwide, implementing all necessary anti-counterfeiting measures and complying with serialisation and anti-tampering requirements of different countries is an absolute prerequisite on the company’s agenda. As part of its large-scale compliance project, the pharmaceutical company equipped its production lines with state-of-the-art serialisation and aggregation technology from WIPOTEC-OCS. Boehringer Ingelheim’s strategic investment has led to a successful implementation and assuring the reliable anti-counterfeit protection combined with serialisation of pharmaceutical products and thereby meeting the ultimate goal of enhancing patient health and safety.

Would you like to see the Traceable Quality System at work in the Boehringer Ingelheim packaging center? Watch the video here.

Back
Product finder

3 steps to your solution

Newsletter

Stay up-to-date!

This website uses cookies. By using this website, you agree to the placement of cookies. More information

Accept